Finzati - Logo
SLNO logo

Soleno Therapeutics, Inc.

SLNO • Biotechnology
$52.99
▼ -0.02 (-0.04%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$2.81B
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Stable or improving margins · 11.0%Positive free cash flow · 0.88Manageable debt level · 0.01Healthy liquidity · 5.8Expensive earnings multiple · 117.86
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$52.99
Change-0.04%
Shares Out53.07M
Market Cap$2.81B
Enterprise Value$2.56B
52W Range29.43 - 90.32
Beta-2.22
P/E29.29
P/S9.87
P/B5.67
P/FCF26.64
EV/Sales8.99

Investment DNA

How strong this company looks for long-term investors

54
out of 100
Business Quality
Margins, moat, returns
62/100
Financial Strength
Debt, cash, stability
79/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
28/100
Why this score▼
Stable or improving margins · 11.0%Positive free cash flow · 0.88Manageable debt level · 0.01Healthy liquidity · 5.8Expensive earnings multiple · 117.86

Analyst view

Analyst sentiment and price target

SLNO
Analyst sentiment
Based on 13 analyst votes · 2026-10-20
81/100
Bullish
Bullish
8
Hold
5
Bearish
0
Price Target
2026-06-06
Low
$53.00
Mean
$80.00
Median
$80.00
High
$107.00

Company Overview

IPO: 11/13/2014
Industry: Biotechnology
P/B i: 5.67
Debt / Equity i: 0.01
Operating Margin: 7.85%
Net Margin: 10.97%
ROE i: -
ROIC: -

Financial Health

Score16 / 20
Debt / Equity: 0.01
Current Ratio: 5.80
Quick Ratio: 5.55
Status: Strong

Insider Transactions

Recent executive and insider activity

⚠ 2 high-volume insider sells detected
Anish Bhatnagar
Transaction: 05/18/2026
SELL
Change
-131,400
Price
$43.65
Filing
05/18/2026
Type
SELL
Anish Bhatnagar
Transaction: 05/18/2026
SELL
Change
-583,656
Price
Not reported
Filing
05/18/2026
Type
SELL
Bir Dawn Carter
Transaction: 05/18/2026
SELL
Change
-16,991
Price
Not reported
Filing
05/18/2026
Type
SELL